Craig joined INVO Bioscience in January 2022. Craig has been a key advisor to medical device and specialty pharmaceutical companies with responsibilities encompassing product launches, strategic communications, and market expansion initiatives. He possesses 20 years of intensive sector experience including engagements with divisions of OPKO Health, Option Care Health, and Opsens. He is a graduate of Columbia University.
January, 2022 - present